Allan J Pantuck

Title(s)Department Vice Chair, Urology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor-in-residence, Urology


    Collapse Research 
    Collapse Research Activities and Funding
    Genetic and molecular characterization of kidney cancer
    NIH K23CA095151Sep 23, 2002 - Aug 31, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol. 2024 Oct; 25(10):1277-1287. Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, Önal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P. PMID: 39270701.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    2. Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas. J Immunother. 2024 Nov-Dec 01; 47(9):351-360. Faiena I, Adhikary S, Schweitzer C, Astrow SH, Grogan T, Funt SA, Bot A, Dorff T, Rosenberg JE, Elashoff DA, Pantuck AJ, Drakaki A. PMID: 39169899; PMCID: PMC11446647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review. JCO Precis Oncol. 2024 Jun; 8:e2400154. Kathuria-Prakash N, Lopez LP, Raman S, Ye H, Anaokar J, Sisk A, Pantuck AJ, Drakaki A. PMID: 38885453.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma. Cancer Invest. 2024 Jan; 42(1):97-103. Lebacle C, Pooli A, Shuch B, Rao N, Chamie K, Kroeger N, Faiena I, Liu S, Wood EL, Belldegrun A, Drakaki A, Pantuck AJ. PMID: 38314786.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2024 04; 22(2):347-353. Huang RR, Chen Z, Kroeger N, Pantuck A, Said J, Kluger HM, Shuch B, Ye H. PMID: 38195301.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma. Curr Oncol. 2023 08 04; 30(8):7398-7411. Hui G, Stefanoudakis D, Zektser Y, Isaacs DJ, Hannigan C, Pantuck AJ, Drakaki A. PMID: 37623017; PMCID: PMC10452970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. The Potential Revolution of Cancer Treatment with CRISPR Technology. Cancers (Basel). 2023 Mar 17; 15(6). Stefanoudakis D, Kathuria-Prakash N, Sun AW, Abel M, Drolen CE, Ashbaugh C, Zhang S, Hui G, Tabatabaei YA, Zektser Y, Lopez LP, Pantuck A, Drakaki A. PMID: 36980699; PMCID: PMC10046289.
      View in: PubMed   Mentions: 13  
    8. Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer. Cancer Med. 2023 03; 12(5):6437-6444. Patel N, Hakansson A, Ohtake S, Muraki P, Proudfout JA, Liu Y, Webber L, Ibarra A, Liu VYT, Davicioni E, Chamie K, Pantuck A, Shuch B. PMID: 36397716; PMCID: PMC10028022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol. 2022 07; 23(7):910-918. Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh QD, Durack JC, Akin O, Vickers AJ, Scardino PT, Sperling D, Wong JYC, Yuh B, Woodrum DA, Mynderse LA, Raman SS, Pantuck AJ, Schiffman MH, McClure TD, Sonn GA, Ghanouni P. PMID: 35714666; PMCID: PMC9400094.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    10. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma. Eur J Cancer. 2022 06; 168:68-76. Kroeger N, Lebacle C, Hein J, Rao PN, Nejati R, Wei S, Burchardt M, Drakaki A, Strother M, Kutikov A, Uzzo R, Pantuck AJ. PMID: 35461012.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2021 10 01; 27(19):5248-5257. Sarker D, Dawson NA, Aparicio AM, Dorff TB, Pantuck AJ, Vaishampayan UN, Henson L, Vasist L, Roy-Ghanta S, Gorczyca M, York W, Ganji G, Tolson J, de Bono JS. PMID: 34281912.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    12. Reply by Authors. J Urol. 2021 03; 205(3):779. Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S. PMID: 33355501.
      View in: PubMed   Mentions: 1     Fields:    
    13. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. J Immunother. 2020 Nov/Dec; 43(9):273-282. Faiena I, Comin-Anduix B, Berent-Maoz B, Bot A, Zomorodian N, Sachdeva A, Said J, Cheung-Lau G, Pang J, Macabali M, Chodon T, Wang X, Cabrera P, Kaplan-Lefko P, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A. PMID: 32925563.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    14. Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting. Future Oncol. 2021 Feb; 17(4):403-409. Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ. PMID: 33028084; PMCID: PMC8488532.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer. J Urol. 2021 Mar; 205(3):769-779. Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S. PMID: 33021440.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    16. Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma. Abdom Radiol (NY). 2020 10; 45(10):3184-3192. Coy H, Young JR, Pantuck AJ, Douek ML, Sisk A, Magyar C, Brown MS, Sayre J, Raman SS. PMID: 31650375.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    17. "Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma. Urol Oncol. 2021 01; 39(1):76.e15-76.e22. Drakaki A, Pantuck A, Mhatre SK, Dhillon PK, Davarpanah N, Degaonkar V, Surinach A, Chamie K, Grivas P. PMID: 32778476.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer. Clin Cancer Res. 2020 10 15; 26(20):5338-5347. Aggarwal RR, Schweizer MT, Nanus DM, Pantuck AJ, Heath EI, Campeau E, Attwell S, Norek K, Snyder M, Bauman L, Lakhotia S, Feng FY, Small EJ, Abida W, Alumkal JJ. PMID: 32694156; PMCID: PMC7572827.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    19. Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial. Clin Cancer Res. 2020 09 15; 26(18):4863-4868. Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ. PMID: 32546645; PMCID: PMC7501085.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    20. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC). J Immunother Cancer. 2019 12 20; 7(1):354. Rini BI, Battle D, Figlin RA, George DJ, Hammers H, Hutson T, Jonasch E, Joseph RW, McDermott DF, Motzer RJ, Pal SK, Pantuck AJ, Quinn DI, Seery V, Voss MH, Wood CG, Wood LS, Atkins MB. PMID: 31856918; PMCID: PMC6924043.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    21. Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients. J Vasc Interv Radiol. 2020 Jan; 31(1):15-24. Marshall HR, Shakeri S, Hosseiny M, Sisk A, Sayre J, Lu DS, Pantuck A, Raman S. PMID: 31767409.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. BMC Med. 2019 10 03; 17(1):182. Klatte T, Gallagher KM, Afferi L, Volpe A, Kroeger N, Ribback S, McNeill A, Riddick ACP, Armitage JN, 'Aho TF, Eisen T, Fife K, Bex A, Pantuck AJ, Stewart GD. PMID: 31578141; PMCID: PMC6775651.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    23. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. Urol Oncol. 2020 01; 38(1):1.e17-1.e23. Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 31537483.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients. World J Urol. 2020 Jun; 38(6):1525-1533. Heide J, Ribback S, Klatte T, Shariat S, Burchardt M, Dombrowski F, Belldegrun AS, Drakaki A, Pantuck AJ, Kroeger N. PMID: 31520111.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas. Abdom Radiol (NY). 2019 06; 44(6):2308-2315. Shakeri S, Afshari Mirak S, Mohammadian Bajgiran A, Pantuck A, Sisk A, Ahuja P, Lu DS, Raman SS. PMID: 30847565.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    26. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 09; 37(9):577.e9-577.e16. Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30930099; PMCID: PMC6698401.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    27. Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma. Cancer Immunol Immunother. 2019 May; 68(5):743-751. Faiena I, Astrow SH, Elashoff DA, Jain R, Bot A, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A. PMID: 30790015; PMCID: PMC11028196.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Clear cell renal cell carcinoma: identifying PTEN expression on multiphasic MDCT. Abdom Radiol (NY). 2018 12; 43(12):3410-3417. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS. PMID: 29946925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? Urol Oncol. 2019 01; 37(1):63-70. Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30446452.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis. Clin Cancer Res. 2019 02 15; 25(4):1165-1173. George DJ, Martini JF, Staehler M, Motzer RJ, Magheli A, Donskov F, Escudier B, Li S, Casey M, Valota O, Laguerre B, Pantuck AJ, Pandha HS, Patel A, Lechuga M, Ravaud A. PMID: 30401688; PMCID: PMC6669904.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    31. Editorial Comment on: Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses by Ayangbesan et al. (From: Ayangbesan A, Golombos DM, Golan R, et al. J Endourol 2019;33:50-60; DOI: 10.1089/end.2018.0144). J Endourol. 2019 01; 33(1):61. Johnson DC, Pantuck AJ. PMID: 30200775.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma. AJR Am J Roentgenol. 2018 12; 211(6):1254-1258. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS. PMID: 30300009.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression. Abdom Radiol (NY). 2018 10; 43(10):2734-2742. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Belldegrun A, Pantuck AJ, Raman SS. PMID: 29520426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. World J Urol. 2019 Jun; 37(6):1157-1164. Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30267197; PMCID: PMC6438772.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urol Oncol. 2018 12; 36(12):527.e13-527.e19. Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 30228094.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    36. Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies. Clin Genitourin Cancer. 2019 Feb; 17(1):65-71. Kroeger N, Li H, De Velasco G, Donskov F, Sim HW, Stühler V, Wells JC, Stukalin I, Heide J, Bedke J, Agarwal N, Parekh H, Rini BI, Knox JJ, Pantuck A, Choueiri TK, Chin Heng DY. PMID: 30341028.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma. Urol Oncol. 2018 11; 36(11):502.e15-502.e24. Steven A, Leisz S, Fussek S, Nowroozizadeh B, Huang J, Branstetter D, Dougall WC, Burchardt M, Belldegrun AS, Seliger B, Pantuck A, Kroeger N. PMID: 30170981.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance. Abdom Radiol (NY). 2018 07; 43(7):1813-1819. Alle N, Tan N, Huss J, Huang J, Pantuck A, Raman SS. PMID: 29079986.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype. Abdom Radiol (NY). 2018 06; 43(6):1472-1477. McClure T, Pantuck A, Sayer J, Raman S. PMID: 28936542.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J Urol. 2019 Jan; 37(1):115-123. Lebacle C, Pooli A, Bessede T, Irani J, Pantuck AJ, Drakaki A. PMID: 29858701.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    41. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. World J Urol. 2018 Nov; 36(11):1825-1833. Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. PMID: 29752514.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer. Mol Cancer Ther. 2018 07; 17(7):1430-1440. Koutsioumpa M, Chen HW, O'Brien N, Koinis F, Mahurkar-Joshi S, Vorvis C, Soroosh A, Luo T, Issakhanian S, Pantuck AJ, Georgoulias V, Iliopoulos D, Slamon DJ, Drakaki A. PMID: 29703843.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    43. Re: Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. Eur Urol. 2018 06; 73(6):981. Faiena I, Salmasi A, Pantuck AJ, Drakaki A. PMID: 29433974.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy. Eur Urol. 2018 07; 74(1):119-121. Salmasi A, Faiena I, Drakaki A, Pantuck AJ. PMID: 29433972.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study. Clin Cancer Res. 2018 04 01; 24(7):1554-1561. George DJ, Martini JF, Staehler M, Motzer RJ, Magheli A, Escudier B, Gerletti P, Li S, Casey M, Laguerre B, Pandha HS, Pantuck AJ, Patel A, Lechuga MJ, Ravaud A. PMID: 29374054.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    46. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018; 12:209-215. Faiena I, Cummings AL, Crosetti AM, Pantuck AJ, Chamie K, Drakaki A. PMID: 29416316; PMCID: PMC5789049.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    47. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018 Mar; 36(3):409-416. Bachour K, Faiena I, Salmasi A, Lenis AT, Johnson DC, Pooli A, Drakaki A, Pantuck AJ, Chamie K. PMID: 29299664.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018 02; 36(2):78.e21-78.e28. Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29128421.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    49. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era. Clin Genitourin Cancer. 2018 04; 16(2):e269-e276. Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A. PMID: 29199023.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    50. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol Oncol. 2018 02; 36(2):79.e19-79.e26. Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, Drakaki A, Belldegrun AS, Pantuck AJ, Chamie K. PMID: 29103965.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Optimizing peptide epitope-based autoantibody detection in cancer patients. Am J Clin Exp Immunol. 2017; 6(5):84-91. Wang M, Lomeli SH, Franklin WA, Lee S, Pantuck AJ, Zeng G. PMID: 29181273; PMCID: PMC5698562.
      View in: PubMed   Mentions:
    52. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urol Oncol. 2018 01; 36(1):9.e1-9.e9. Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K. PMID: 29066013.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    53. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol. 2018 01; 73(1):62-68. Motzer RJ, Ravaud A, Patard JJ, Pandha HS, George DJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Casey M, Serfass L, Pantuck AJ, Staehler M. PMID: 28967554; PMCID: PMC6684251.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    54. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT. Abdom Radiol (NY). 2017 07; 42(7):1911-1918. Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS. PMID: 28265706.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017 Jul 01; 3(7):913-920. Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJA, Pantuck AJ, Belldegrun AS. PMID: 27787547; PMCID: PMC5824229.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    56. High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial. J Urol. 2018 01; 199(1):133-139. Jones TA, Chin J, Mcleod D, Barkin J, Pantuck A, Marks LS. PMID: 28652121.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    57. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight. 2017 Jun 15; 2(12). Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E, Wang PI, Nanjangud GJ, Redzematovic A, Nargund AM, Manley BJ, Arcila ME, Donin NM, Cheville JC, Thompson RH, Pantuck AJ, Russo P, Cheng EH, Lee W, Tickoo SK, Ostrovnaya I, Creighton CJ, Papaemmanuil E, Seshan VE, Hakimi AA, Hsieh JJ. PMID: 28614790; PMCID: PMC5470887.
      View in: PubMed   Mentions: 47     Fields:    
    58. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. Acad Radiol. 2017 10; 24(10):1226-1232. Young JR, Young JA, Margolis DJA, Sauk S, Sayre J, Pantuck AJ, Raman SS. PMID: 28528853.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Clear Cell Renal Cell Carcinoma: Identifying the Loss of the Y Chromosome on Multiphasic MDCT. AJR Am J Roentgenol. 2017 Aug; 209(2):333-338. Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS. PMID: 28504543.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    60. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. J Urol. 2018 01; 199(1):43-52. Lenis AT, Donin NM, Johnson DC, Faiena I, Salmasi A, Drakaki A, Belldegrun A, Pantuck A, Chamie K. PMID: 28479237; PMCID: PMC5720927.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    61. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017 10; 198(4):839-847. Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, Felker E, Margolis DJA, Sisk A, Pantuck A, Grundfest W, Marks LS. PMID: 28396184.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    62. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. AJR Am J Roentgenol. 2017 Apr; 208(4):812-819. Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS. PMID: 28125273.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    63. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility. Urol Oncol. 2017 05; 35(5):272-278. Donin NM, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Lenis AT, Holden S, Pantuck AJ, Belldegrun AS, Chamie K. PMID: 28065395.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    64. Clear cell renal cell carcinoma: identifying the gain of chromosome 12 on multiphasic MDCT. Abdom Radiol (NY). 2017 01; 42(1):236-241. Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS. PMID: 27519835.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    65. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer. Brachytherapy. 2017 Mar - Apr; 16(2):299-305. Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park SJ, Marks L, Pantuck A, Steinberg M, Kamrava M. PMID: 27965117.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    66. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma. J Immunother Cancer. 2016; 4:81. Rini BI, McDermott DF, Hammers H, Bro W, Bukowski RM, Faba B, Faba J, Figlin RA, Hutson T, Jonasch E, Joseph RW, Leibovich BC, Olencki T, Pantuck AJ, Quinn DI, Seery V, Voss MH, Wood CG, Wood LS, Atkins MB. PMID: 27891227; PMCID: PMC5109802.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    67. Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT. Abdom Radiol (NY). 2016 11; 41(11):2175-2181. Young JR, Young JA, Margolis DJ, Sauk S, Pantuck AJ, Sayre J, Raman SS. PMID: 27315079.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    68. A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer. Urol Oncol. 2017 02; 35(2):39.e1-39.e7. Donin NM, Chamie K, Lenis AT, Pantuck AJ, Reddy M, Kivlin D, Holldack J, Pozzi R, Hakim G, Karsh LI, Lamm DL, Belkoff LH, Belldegrun AS, Holden S, Shore N. PMID: 28341495.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    69. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol. 2017 06; 71(6):970-978. Davis ID, Xie W, Pezaro C, Donskov F, Wells JC, Agarwal N, Srinivas S, Yuasa T, Beuselinck B, Wood LA, Ernst DS, Kanesvaran R, Knox JJ, Pantuck A, Saleem S, Alva A, Rini BI, Lee JL, Choueiri TK, Heng DYC. PMID: 27771126.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    70. Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy. N Engl J Med. 2016 12 08; 375(23):2246-2254. Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Martini JF, Ramaswamy K, Casey M, Staehler M, Patard JJ, S-TRAC Investigators. PMID: 27718781.
      View in: PubMed   Mentions: 285     Fields:    Translation:HumansCTClinical Trials
    71. Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study. Urology. 2017 Jan; 99:270-277. Donin NM, Duarte S, Lenis AT, Caliliw R, Torres C, Smithson A, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Said J, Raman SS, Holden S, Pantuck A, Belldegrun AS, Chamie K. PMID: 27720772.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    72. Immunotherapy for the Treatment of Urothelial Carcinoma. J Urol. 2017 01; 197(1):14-22. Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, Chamie K. PMID: 27460757.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    73. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016 09; 25(9):1326-32. Donin NM, Pantuck A, Klöpfer P, Bevan P, Fall B, Said J, Belldegrun AS, Chamie K. PMID: 27418270.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A. 2016 Feb 23; 113(8):2170-5. Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. PMID: 26864202; PMCID: PMC4776463.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    75. The Role of Adrenalectomy in Renal Cancer. Eur Urol Focus. 2016 Feb; 1(3):251-257. Weight CJ, Mulders PF, Pantuck AJ, Thompson RH. PMID: 28723393.
      View in: PubMed   Mentions: 4     Fields:    
    76. Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients. Int J Clin Exp Med. 2015; 8(7):11470-6. Miles FL, Rao JY, Eckhert C, Chang SC, Pantuck A, Zhang ZF. PMID: 26379965; PMCID: PMC4565348.
      View in: PubMed   Mentions: 2  
    77. Prognostication in localised renal cell carcinoma. Lancet Oncol. 2015 Jun; 16(6):603-4. Kroeger N, Zimmermann U, Burchardt M, Pantuck AJ. PMID: 25979596.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner. Asian J Urol. 2015 Jan; 2(1):38-45. An J, Guo Y, Wang T, Pantuck AJ, Rettig MB. PMID: 29264118; PMCID: PMC5730684.
      View in: PubMed   Mentions: 8  
    79. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial. Urol Oncol. 2015 May; 33(5):204.e25-33. Chamie K, Klöpfer P, Bevan P, Störkel S, Said J, Fall B, Belldegrun AS, Pantuck AJ. PMID: 25823535.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    80. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. Eur Urol. 2015 Sep; 68(3):506-15. Kroeger N, Pantuck AJ, Wells JC, Lawrence N, Broom R, Kim JJ, Srinivas S, Yim J, Bjarnason GA, Templeton A, Knox J, Bernstein E, Smoragiewicz M, Lee J, Rini BI, Vaishampayan UN, Wood LA, Beuselinck B, Donskov F, Choueiri TK, Heng DY. PMID: 25524810.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    81. The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2015 Feb 01; 21(3):561-8. McDermott DF, Cheng SC, Signoretti S, Margolin KA, Clark JI, Sosman JA, Dutcher JP, Logan TF, Curti BD, Ernstoff MS, Appleman L, Wong MK, Khushalani NI, Oleksowicz L, Vaishampayan UN, Mier JW, Panka DJ, Bhatt RS, Bailey AS, Leibovich BC, Kwon ED, Kabbinavar FF, Belldegrun AS, Figlin RA, Pantuck AJ, Regan MM, Atkins MB. PMID: 25424850; PMCID: PMC4315731.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    82. The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urol Oncol. 2015 Feb; 33(2):68.e1-7. Hofbauer SL, Pantuck AJ, de Martino M, Lucca I, Haitel A, Shariat SF, Belldegrun AS, Klatte T. PMID: 25240758.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    83. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. J Vasc Interv Radiol. 2014 Nov; 25(11):1682-8; quiz 1689. McClure TD, Chow DS, Tan N, Sayre JA, Pantuck AJ, Raman SS. PMID: 25081202.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    84. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff. Urol Oncol. 2014 Oct; 32(7):1024-30. Pignot G, Bigot P, Bernhard JC, Bouliere F, Bessede T, Bensalah K, Salomon L, Mottet N, Bellec L, Soulié M, Ferrière JM, Pfister C, Drai J, Colombel M, Villers A, Rigaud J, Bouchot O, Montorsi F, Bertini R, Belldegrun AS, Pantuck AJ, Patard JJ. PMID: 24996775.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. Re: Grant D. Stewart, Fiach C. O'Mahony, Alexander Laird, et al. carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.007. Eur Urol. 2014 Oct; 66(4):e69-70. Kroeger N, Pantuck AJ. PMID: 24973996.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. The contemporary role on surgery in the management of renal masses. World J Urol. 2014 Jun; 32(3):571-2. Kroeger N, Belldegrun AS, Pantuck AJ. PMID: 24718636.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p. Abdom Imaging. 2014 Jun; 39(3):543-9. Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Young JA, Hsu M, Raman SS. PMID: 24573763.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    88. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol. 2014 Jun; 32(3):597-605. Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. PMID: 24700308.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    89. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α. Eur J Cancer. 2014 May; 50(8):1531-40. Kroeger N, Seligson DB, Signoretti S, Yu H, Magyar CE, Huang J, Belldegrun AS, Pantuck AJ. PMID: 24565854.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    90. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res (Phila). 2013 Oct; 6(10):1120-7. Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, Kerkoutian S, Wu H, Li Y, Creel P, Mundy K, Gurganus R, Fedor H, King SA, Zhang Y, Heber D, Pantuck AJ. PMID: 23985577; PMCID: PMC3806642.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    91. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013 Dec; 190(6):1999-2004. de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. PMID: 23831313.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    92. Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience. Cancer J. 2013 May-Jun; 19(3):189-96. Birkhäuser FD, Pantuck AJ, Rampersaud EN, Wang X, Kroeger N, Pouliot F, Zomorodian N, Riss J, Li G, Kabbinavar FF, Belldegrun AS. PMID: 23708063.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol. 2014 Jan; 32(1):30.e9-13. Rampersaud EN, Klatte T, Bass G, Patard JJ, Bensaleh K, Böhm M, Allhoff EP, Cindolo L, De La Taille A, Mejean A, Soulie M, Bellec L, Christophe Bernhard J, Pfister C, Colombel M, Belldegrun AS, Pantuck AJ, George D. PMID: 23422777.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    94. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013 May; 267(2):444-53. Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. PMID: 23382290.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    95. Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models. J Immunother. 2013 Feb; 36(2):102-11. Birkhäuser FD, Koya RC, Neufeld C, Rampersaud EN, Lu X, Micewicz ED, Chodon T, Atefi M, Kroeger N, Chandramouli GV, Li G, Said JW, McBride WH, Kabbinavar FF, Ribas A, Pantuck AJ, Belldegrun AS, Riss J. PMID: 23377663; PMCID: PMC6410717.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    96. Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma. Cancer. 2013 Apr 15; 119(8):1547-54. Kroeger N, Klatte T, Chamie K, Rao PN, Birkhäuser FD, Sonn GA, Riss J, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 23335244.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    97. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2013 Jan 10; 368(2):138-48. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE, COU-AA-302 Investigators. PMID: 23228172; PMCID: PMC3683570.
      View in: PubMed   Mentions: 1107     Fields:    Translation:Humans
    98. IGFBP-3 nuclear localization predicts human prostate cancer recurrence. Horm Cancer. 2013 Feb; 4(1):12-23. Seligson DB, Yu H, Tze S, Said J, Pantuck AJ, Cohen P, Lee KW. PMID: 23011725; PMCID: PMC3541441.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    99. Applicability of a disposable home urinary flow measuring device as a diagnostic tool in the management of males with lower urinary tract symptoms. Urol Int. 2012; 89(2):166-72. Heesakkers J, Farag F, Pantuck A, Moore K, Radziszewski P, Lucas M. PMID: 22797567.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    100. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer. 2012 Dec 01; 118(23):5777-82. Klatte T, Kroeger N, Rampersaud EN, Birkhäuser FD, Logan JE, Sonn G, Riss J, Rao PN, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 22605478.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    101. Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol. 2012 May; 61(5):888-95. Kroeger N, Seligson DB, Klatte T, Rampersaud EN, Birkhäuser FD, Rao PN, Leppert JT, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 22269604.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    102. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012 Jun; 109(11):1600-6. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS. PMID: 22221668; PMCID: PMC4676716.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    103. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012; 14(3-4):65-78. Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, Slamon DJ, Kabbinavar FF. PMID: 23526579; PMCID: PMC3602729.
      View in: PubMed   Mentions: 16  
    104. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol. 2012 Feb; 187(2):418-23. Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhäuser FD, Shariat SF, Lang H, Rioux-Leclerq N, Remzi M, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 22177164.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    105. Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes. Radiology. 2011 Dec; 261(3):854-62. Sauk SC, Hsu MS, Margolis DJ, Lu DS, Rao NP, Belldegrun AS, Pantuck AJ, Raman SS. PMID: 22025734.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    106. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. J Urol. 2011 Dec; 186(6):2168-74. Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 22014797.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    107. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer. 2012 Apr 01; 118(7):1795-802. Kroeger N, Klatte T, Birkhäuser FD, Rampersaud EN, Seligson DB, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 21997347.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    108. Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer. J Urol. 2011 Sep; 186(3):877-81. Hall SJ, Klotz L, Pantuck AJ, George DJ, Whitmore JB, Frohlich MW, Sims RB. PMID: 21788048.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    109. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011 Oct; 60(4):644-61. Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, Pantuck AJ, Zigeuner R, Karakiewicz PI. PMID: 21741163.
      View in: PubMed   Mentions: 145     Fields:    Translation:Humans
    110. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. J Transl Med. 2011 Apr 19; 9:43. Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, Zeng G. PMID: 21504557; PMCID: PMC3102624.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    111. Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time. Can Urol Assoc J. 2011 Apr; 5(2):89-95. Pouliot F, Pantuck A, Imbeault A, Shuch B, Calimlim B, Audet JF, Finley DS, Dujardin T. PMID: 21470531; PMCID: PMC3104439.
      View in: PubMed   Mentions: 10  
    112. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728. Shuch B, Crispen PL, Leibovich BC, LaRochelle JC, Pouliot F, Pantuck AJ, Liu W, Crepel M, Schuckman A, Rigaud J, Bouchot O, Patard JJ, Skinner D, Belldegrun AS, Blute ML. PMID: 20626391.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    113. Use of abiraterone for prostate cancer. J Urol. 2011 Mar; 185(3):783-6. Mohler JL, Pantuck AJ. PMID: 21239011.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist. 2011; 16 Suppl 2:4-13. Finley DS, Pantuck AJ, Belldegrun AS. PMID: 21346035; PMCID: PMC3868202.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    115. Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance. BJU Int. 2011 Aug; 108(3):343-8. Shuch B, Pantuck AJ, Pouliot F, Finley DS, Said JW, Belldegrun AS, Saigal C. PMID: 21087450.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    116. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol. 2011 Jan; 185(1):30-5. Klatte T, Said JW, Seligson DB, Rao PN, de Martino M, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 21074210.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    117. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer. 2010 Nov 01; 127(9):2169-82. Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Pantuck A, Papp JC, Park SL, Rao JY, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. PMID: 20112337; PMCID: PMC2932751.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    118. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma. Cancer. 2010 Oct 15; 116(20):4696-702. La Rochelle J, Klatte T, Dastane A, Rao N, Seligson D, Said J, Shuch B, Zomorodian N, Kabbinavar F, Belldegrun A, Pantuck AJ. PMID: 20629029.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    119. Contemporary management of renal tumors with venous tumor thrombus. J Urol. 2010 Sep; 184(3):833-41; quiz 1235. Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS. PMID: 20643450.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    120. Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al. Eur Urol. 2010 Sep; 58(3):466. Finley DS, Pouliot F, Pantuck A. PMID: 20845530.
      View in: PubMed   Mentions: 1     Fields:    
    121. Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma. J Urol. 2010 Jun; 183(6):2143-7. Klatte T, Anterasian C, Said JW, de Martino M, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 20399450.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    122. Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings--a multicenter survey. Urology. 2010 Sep; 76(3):541-6. Zisman A, Patard JJ, Raz O, Klatte T, Haifler M, Mendlovic S, Sandbank J, Belldegrun AS, Lindner A, Leibovici D, Pantuck AJ. PMID: 20494411.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    123. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis. 2010 Jul; 31(7):1264-71. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF. PMID: 20478923; PMCID: PMC2893801.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    124. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma. J Urol. 2010 Jul; 184(1):53-8. Klatte T, Remzi M, Zigeuner RE, Mannweiler S, Said JW, Kabbinavar FF, Haitel A, Waldert M, de Martino M, Marberger M, Belldegrun AS, Pantuck AJ. PMID: 20478577.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    125. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol. 2010 Jun; 183(6):2403-8. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. PMID: 20403620.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    126. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol. 2010 Jun; 57(6):1080-6. Bernhard JC, Pantuck AJ, Wallerand H, Crepel M, Ferrière JM, Bellec L, Maurice-Tison S, Robert G, Albouy B, Pasticier G, Soulie M, Lopes D, Lacroix B, Bensalah K, Pfister C, Thuret R, Tostain J, De La Taille A, Salomon L, Abbou C, Colombel M, Belldegrun AS, Patard JJ. PMID: 20188458.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    127. Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy. Cancer. 2010 Feb 01; 116(3):616-24. Shuch B, Said J, LaRochelle JC, Zhou Y, Li G, Klatte T, Pouliot F, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19998348; PMCID: PMC3162346.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    128. Editorial comment. J Urol. 2010 Mar; 183(3):914. Pantuck AJ. PMID: 20083263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas. Cancer Res. 2010 Jan 15; 70(2):752-61. Pantuck AJ, An J, Liu H, Rettig MB. PMID: 20068166.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    130. Editorial comment. J Urol. 2010 Jan; 183(1):41-2. Pantuck AJ. PMID: 19913244.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    131. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res. 2010 Feb; 20(1):55-62. Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D, Pantuck AJ, Cohen P. PMID: 19853487; PMCID: PMC2815223.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    132. Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol. 2009 Dec; 182(6):2607-12. Karakiewicz PI, Suardi N, Capitanio U, Isbarn H, Jeldres C, Perrotte P, Sun M, Ficarra V, Zigeuner R, Tostain J, Mejean A, Cindolo L, Pantuck AJ, Belldegrun AS, Zini L, de la Taille A, Chautard D, Descotes JL, Shariat SF, Valeri A, Mulders PF, Lang H, Lechevallier E, Patard JJ. PMID: 19836798.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    133. Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable? J Urol. 2009 Nov; 182(5):2164-71. Shuch B, Said J, La Rochelle JC, Zhou Y, Li G, Klatte T, Kabbinaavar FF, Pantuck AJ, Belldegrun AS. PMID: 19758641; PMCID: PMC3175230.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    134. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. J Urol. 2009 Aug; 182(2):728-34. de Martino M, Klatte T, Seligson DB, LaRochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 19539328.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    135. Words of wisdom. Re: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo- controlled phase III trial. Eur Urol. 2009 Jun; 55(6):1482-4. Pouliot F, Pantuck AJ. PMID: 19650239.
      View in: PubMed   Mentions: 1     Fields:    
    136. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer. 2009 Apr 01; 115(7):1448-58. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ. PMID: 19195047.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    137. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol. 2010 Mar; 57(3):466-71. Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Piñeiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ. PMID: 19359089.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    138. Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol. 2009 May; 181(5):2037-42; discussion 2043. La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A. PMID: 19298974.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    139. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):894-900. Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 19240241.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    140. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol. 2009 Apr; 181(4):1558-64; discussion 1563-4. Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, Thomas GV, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19230920.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    141. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res. 2009 Feb 15; 15(4):1162-9. Klatte T, Pantuck AJ, Said JW, Seligson DB, Rao NP, LaRochelle JC, Shuch B, Zisman A, Kabbinavar FF, Belldegrun AS. PMID: 19228721.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    142. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009 Feb 10; 27(5):746-53. Klatte T, Rao PN, de Martino M, LaRochelle J, Shuch B, Zomorodian N, Said J, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 19124809.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    143. Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol. 2009 Feb; 181(2):492-8; discussion 498-9. Shuch B, Larochelle JC, Onyia T, Vallera C, Margulis D, Pantuck AJ, Smith RB, Belldegrun AS. PMID: 19110280.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    144. Molecular biology of renal cortical tumors. Urol Clin North Am. 2008 Nov; 35(4):573-80; vi. Klatte T, Pantuck AJ. PMID: 18992611.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    145. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer. 2008 Nov 01; 113(9):2457-63. Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Dekernion JB, Pantuck AJ. PMID: 18823034.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    146. Chemoprevention of bladder cancer. BJU Int. 2008 Nov; 102(9 Pt B):1274-8. La Rochelle J, Kamat A, Grossman HB, Pantuck A. PMID: 19035892.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    147. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3193-202. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. PMID: 18990762; PMCID: PMC2664075.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    148. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer. 2008 Oct 01; 113(7):1641-8. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 18671240.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    149. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer. 2008 Sep 15; 113(6):1324-31. Shuch B, La Rochelle JC, Wu J, Klatte T, Riggs SB, Kabbinavar F, Belldegrun AS, Pantuck AJ. PMID: 18661529.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    150. The staging of renal cell carcinoma. Curr Opin Urol. 2008 Sep; 18(5):455-61. Shuch B, La Rochelle JC, Pantuck AJ, Belldegrun AS. PMID: 18670267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Cancer Ther. 2008 Sep; 7(9):2662-71. Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A. PMID: 18790748; PMCID: PMC2858627.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    152. Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int. 2008 Nov; 102(10):1376-80. Bensalah K, Pantuck AJ, Crepel M, Verhoest G, Méjean A, Valéri A, Ficarra V, Pfister C, Ferrière JM, Soulié M, Cindolo L, De La Taille A, Tostain J, Chautard D, Schips L, Zigeuner R, Abbou CC, Lobel B, Salomon L, Lechevallier E, Descotes JL, Guillé F, Colombel M, Belldegrun AS, Patard JJ. PMID: 18727618.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    153. Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer. 2008 Jul 15; 123(2):395-400. Patard JJ, Fergelot P, Karakiewicz PI, Klatte T, Trinh QD, Rioux-Leclercq N, Said JW, Belldegrun AS, Pantuck AJ. PMID: 18464292; PMCID: PMC2721857.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    154. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma. J Clin Oncol. 2008 Jun 20; 26(18):3105-7; author reply 3107-9. Pantuck AJ, Klatte T, Seligson D, Atkins M, Belldegrun A. PMID: 18565906.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    155. The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder. BJU Int. 2008 Jun; 101 Suppl 4:45-8. Klatte T, Belldegrun AS, Pantuck AJ. PMID: 18430124.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    156. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int. 2008 Sep; 102(6):692-6. Shuch B, Riggs SB, LaRochelle JC, Kabbinavar FF, Avakian R, Pantuck AJ, Patard JJ, Belldegrun AS. PMID: 18410444.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    157. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol. 2008 May; 179(5):1719-26. Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 18343437.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    158. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008 Feb; 32(2):475-80. Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D. PMID: 18202771.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    159. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol. 2008 Nov-Dec; 26(6):604-9. Klatte T, Han KR, Said JW, Böhm M, Allhoff EP, Kabbinavar FF, Belldegrun AS, Pantuck AJ. PMID: 18367104.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    160. Genomics and proteomics in renal cell carcinoma: diagnosis, prognosis, and treatment selection. Curr Urol Rep. 2008 Jan; 9(1):9-14. Jones J, Pantuck AJ. PMID: 18366968.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    161. Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. J Urol. 2008 Feb; 179(2):610-5. Shi R, Xie Q, Gang X, Lun J, Cheng L, Pantuck A, Rao J. PMID: 18082217.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    162. Proteomic identification of interleukin-2 therapy response in metastatic renal cell cancer. J Urol. 2008 Feb; 179(2):730-6. Jones J, Otu HH, Grall F, Spentzos D, Can H, Aivado M, Belldegrun AS, Pantuck AJ, Libermann TA. PMID: 18082202; PMCID: PMC3836557.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    163. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res. 2007 Dec 15; 13(24):7388-93. Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS. PMID: 18094421.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    164. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol. 2008 Sep-Oct; 26(5):550-4. Klatte T, Lam JS, Shuch B, Belldegrun AS, Pantuck AJ. PMID: 18774472.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    165. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma. Cancer. 2007 Dec 01; 110(11):2428-33. Hutterer GC, Patard JJ, Colombel M, Belldegrun AS, Pfister C, Guille F, Artibani W, Montorsi F, Pantuck AJ, Karakiewicz PI. PMID: 17941033.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    166. The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol. 2008 Jan; 179(1):61-6. Klatte T, Seligson DB, Leppert JT, Riggs SB, Yu H, Zomorodian N, Kabbinavar FF, Strieter RM, Belldegrun AS, Pantuck AJ. PMID: 17997430.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    167. A novel resectoscope for transurethral resection of bladder tumors and the prostate. J Urol. 2007 Dec; 178(6):2331-6; discussion 2336. Pantuck AJ, Baniel J, Kirkali Z, Klatte T, Zomorodian N, Yossepowitch O, Belldegrun AS. PMID: 17936809.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    168. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol. 2008 Mar; 65(3):235-62. Lam JS, Klatte T, Kim HL, Patard JJ, Breda A, Zisman A, Pantuck AJ, Figlin RA. PMID: 17931881.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    169. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007 Oct; 52(4):1145-6. Pantuck AJ. PMID: 17336450.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    170. Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int. 2007 Oct; 100(4):802-8. Karakiewicz PI, Hutterer GC, Trinh QD, Pantuck AJ, Klatte T, Lam JS, Guille F, de La Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Schips L, Zigeuner R, Mulders PF, Chautard D, Lechevallier E, Valeri A, Descotes JL, Lang H, Soulie M, Ferriere JM, Pfister C, Mejean A, Belldegrun AS, Patard JJ. PMID: 17822461.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    171. The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgery. J Urol. 2007 Nov; 178(5):1892-5; discussion 1895. Raz O, Mendlovic S, Leibovici D, Pantuck AJ, Sandbank J, Sella A, Lindner A, Zisman A. PMID: 17868730.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    172. Ureteral tumor thrombus from renal cell carcinoma extending into bladder. Urol Oncol. 2007 Sep-Oct; 25(5):393-5. Gulati M, Gore JL, Pantuck AJ, Kim Y, Barajas L, Rajfer J. PMID: 17826656.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    173. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem. 2007 Sep 19; 55(19):7732-7. Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A, Heber D. PMID: 17722872.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimals
    174. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol. 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS. PMID: 17698087.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    175. A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer. BMC Cancer. 2007 Jul 27; 7:142. Gross M, Higano C, Pantuck A, Castellanos O, Green E, Nguyen K, Agus DB. PMID: 17662137; PMCID: PMC1941739.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    176. Differential diagnosis of hypercalcemia in renal malignancy. Urology. 2007 Jul; 70(1):179.e7-8. Klatte T, Said JW, Belldegrun AS, Pantuck AJ. PMID: 17656242.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    177. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol. 2007 Jun; 177(6):2081-6; discussion 2086-7. Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ. PMID: 17509291.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    178. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer. 2007 Jun 01; 109(11):2257-67. Pantuck AJ, Seligson DB, Klatte T, Yu H, Leppert JT, Moore L, O'Toole T, Gibbons J, Belldegrun AS, Figlin RA. PMID: 17440983.
      View in: PubMed   Mentions: 143     Fields:    Translation:HumansCells
    179. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol. 2007 Jul; 178(1):35-40; discussion 40. Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS. PMID: 17521678.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    180. The role of molecular markers in the staging of renal cell carcinoma. BJU Int. 2007 May; 99(5 Pt B):1208-11. Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. PMID: 17441912.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    181. Metastatic melanoma to the kidney presenting with renal vein tumor thrombus. Urology. 2007 May; 69(5):982.e7-9. Klatte T, Rao JY, Ribas A, Pantuck AJ. PMID: 17482952.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    182. Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy. J Immunother. 2007 May-Jun; 30(4):417-24. Reckamp KL, Figlin RA, Moldawer N, Pantuck AJ, Belldegrun AS, Burdick MD, Strieter RM. PMID: 17457216.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    183. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007 Jul; 100(1):21-5. Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ. PMID: 17433034.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    184. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol. 2007 Nov; 52(5):1428-36. Karakiewicz PI, Trinh QD, Lam JS, Tostain J, Pantuck AJ, Belldegrun AS, Patard JJ. PMID: 17420085.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    185. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol. 2007 Jul; 52(1):155-62. Lam JS, Klatte T, Patard JJ, Goel RH, Guillè F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Schips L, Zigeuner R, Pantuck AJ, Figlin RA, Belldegrun AS. PMID: 17316970.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    186. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. BJU Int. 2007 Apr; 99(4):821-4. Klatte T, Chung J, Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS. PMID: 17244281.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    187. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol. 2007 Jul; 52(1):148-54. Patard JJ, Pantuck AJ, Crepel M, Lam JS, Bellec L, Albouy B, Lopes D, Bernhard JC, Guillé F, Lacroix B, De La Taille A, Salomon L, Pfister C, Soulié M, Tostain J, Ferriere JM, Abbou CC, Colombel M, Belldegrun AS. PMID: 17240036.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    188. Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 2):667s-670s. Atkins MB, Ernstoff MS, Figlin RA, Flaherty KT, George DJ, Kaelin WG, Kwon ED, Libermann TA, Linehan WM, McDermott DF, Ochoa AC, Pantuck AJ, Rini BI, Rosen MA, Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L. PMID: 17255291.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    189. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy? Clin Cancer Res. 2007 Jan 15; 13(2 Pt 2):693s-696s. Pantuck AJ, Belldegrun AS, Figlin RA. PMID: 17255295.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    190. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 2):703s-708s. Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA. PMID: 17255297.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    191. Understanding the natural biology of kidney cancer: implications for targeted cancer therapy. Rev Urol. 2007; 9(2):47-56. Klatte T, Pantuck AJ, Kleid MD, Belldegrun AS. PMID: 17592537; PMCID: PMC1892626.
      View in: PubMed   Mentions: 19  
    192. Annexin-I as a potential target for green tea extract induced actin remodeling. Int J Cancer. 2007 Jan 01; 120(1):111-20. Xiao GS, Jin YS, Lu QY, Zhang ZF, Belldegrun A, Figlin R, Pantuck A, Yen Y, Li F, Rao J. PMID: 17019707.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    193. Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy. Curr Urol Rep. 2007 Jan; 8(1):3-4. Pantuck AJ, Zomorodian N, Belldegrun AS. PMID: 17239310.
      View in: PubMed   Mentions: 4     Fields:    
    194. Determining the prognosis of patients with renal cell carcinoma: is it time for a re-evaluation? Nat Clin Pract Urol. 2006 Oct; 3(10):510-1. Leppert JT, Pantuck AJ. PMID: 17031370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    195. Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications. Semin Oncol. 2006 Oct; 33(5):607-13. Pantuck AJ, Thomas G, Belldegrun AS, Figlin RA. PMID: 17045090.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    196. Protective effects of plasma carotenoids on the risk of bladder cancer. J Urol. 2006 Sep; 176(3):1192-7. Hung RJ, Zhang ZF, Rao JY, Pantuck A, Reuter VE, Heber D, Lu QY. PMID: 16890724.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    197. Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score. BJU Int. 2006 Aug; 98(2):445-51. Lam JS, Seligson DB, Yu H, Li A, Eeva M, Pantuck AJ, Zeng G, Horvath S, Belldegrun AS. PMID: 16879693.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    198. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 01; 12(13):4018-26. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. PMID: 16818701.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    199. Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an in vitro bladder cancer carcinogenesis model. Mol Cancer Ther. 2006 Jul; 5(7):1754-63. Jin Y, Iwata KK, Belldegrun A, Figlin R, Pantuck A, Zhang ZF, Lieberman R, Rao J. PMID: 16891461.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    200. Long-term outcomes of the surgical management of renal cell carcinoma. World J Urol. 2006 Aug; 24(3):255-66. Lam JS, Belldegrun AS, Pantuck AJ. PMID: 16479388.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    201. Significance of gene expression analysis of renal cell carcinoma. Expert Rev Anticancer Ther. 2006 Feb; 6(2):293-9. Leppert JT, Pantuck AJ. PMID: 16445381.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    202. Phase-II Study of pomegranate juice for men with prostate cancer and increasing PSA. Curr Urol Rep. 2006 Jan; 7(1):7. Pantuck AJ, Zomorodian N, Belldegrun AS. PMID: 16480662.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    203. Prevention of bladder cancer: a review. Eur Urol. 2006 Feb; 49(2):226-34. Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ. PMID: 16413099.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    204. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer. 2005 Dec 01; 104(11):2400-8. Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. PMID: 16240451.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    205. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol. 2005 Oct 15; 175(8):5351-7. Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. PMID: 16210641.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansAnimalsCells
    206. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5730-9. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA. PMID: 16115910.
      View in: PubMed   Mentions: 242     Fields:    Translation:HumansCells
    207. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int. 2005 Aug; 96(3):281-5. Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS. PMID: 16042714.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    208. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol. 2005 Aug; 174(2):466-72; discussion 472; quiz 801. Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. PMID: 16006866.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    209. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 2005 Jun 15; 103(12):2517-25. Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS. PMID: 15880379.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    210. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005 Apr 20; 23(12):2763-71. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guillé F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. PMID: 15837991.
      View in: PubMed   Mentions: 245     Fields:    Translation:Humans
    211. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer. 2005 Mar 20; 114(2):268-73. Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbins PF, Dubinett SM, deKernion JB, Belldegrun AS. PMID: 15540228.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    212. G250: a carbonic anhydrase IX monoclonal antibody. Curr Oncol Rep. 2005 Mar; 7(2):109-15. Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA. PMID: 15717944.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    213. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. J Urol. 2005 Mar; 173(3):725-8. Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ. PMID: 15711252.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    214. Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model. Clin Cancer Res. 2005 Feb 15; 11(4):1675-83. Lu QY, Jin YS, Pantuck A, Zhang ZF, Heber D, Belldegrun A, Brooks M, Figlin R, Rao J. PMID: 15746073.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    215. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol. 2004 Dec; 172(6 Pt 1):2167-71. Patard JJ, Dorey FJ, Cindolo L, Ficarra V, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Belldegrun AS, Pantuck AJ. PMID: 15538224.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    216. Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol. 2004 Sep-Oct; 22(5):410-4. Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS. PMID: 15464922.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    217. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004 Aug 15; 22(16):3316-22. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A, Tostain J, Artibani W, Dinney CP, Wood CG, Swanson DA, Abbou CC, Lobel B, Mulders PF, Chopin DK, Figlin RA, Belldegrun AS. PMID: 15310775.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    218. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol. 2004 Jun; 45(6):692-705. Lam JS, Shvarts O, Pantuck AJ. PMID: 15149740.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    219. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004 Jun; 171(6 Pt 1):2181-5, quiz 2435. Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Mulders PF, Belldegrun AS. PMID: 15126781.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    220. Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma. Urology. 2004 May; 63(5):841-6; discussion 846-7. Han KR, Kim HL, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun AS. PMID: 15134960.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    221. Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer. J Immunother. 2004 May-Jun; 27(3):240-53. Pantuck AJ, van Ophoven A, Gitlitz BJ, Tso CL, Acres B, Squiban P, Ross ME, Belldegrun AS, Figlin RA. PMID: 15076142.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    222. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res. 2004 Apr 15; 10(8):2659-69. Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS, Figlin RA. PMID: 15102668.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    223. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004 Feb; 34(2):86-9. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. PMID: 15067102.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    224. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003 Dec 15; 98(12):2566-75. Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A. PMID: 14669275.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    225. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. J Urol. 2003 Dec; 170(6 Pt 1):2221-4. Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. PMID: 14634383.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    226. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res. 2003 Oct 15; 9(13):4641-52. Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA. PMID: 14581333.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    227. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003 Oct; 170(4 Pt 1):1126-30. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, Kim HL, Lugg J, Childs SJ, Shuman B, Jayson MA, Shore ND, Moore Y, Zisman A, Lee JY, Ugarte R, Mynderse LA, Wilson TM, Sweat SD, Zincke H, Belldegrun AS. PMID: 14501706.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    228. A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma. J Immunother. 2003 Sep-Oct; 26(5):412-9. Gitlitz BJ, Belldegrun AS, Zisman A, Chao DH, Pantuck AJ, Hinkel A, Mulders P, Moldawer N, Tso CL, Figlin RA. PMID: 12973030.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    229. Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies. J Urol. 2003 Sep; 170(3):768-72; discussion 772. Palapattu GS, Pantuck AJ, Dorey F, Said JW, Figlin RA, Belldegrun AS. PMID: 12913694.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    230. Emerging technologies in uroradiologic imaging. Urol Oncol. 2003 Sep-Oct; 21(5):317-26. Janzen NK, Laifer-Narin S, Han KR, Seltzer M, Thomas MA, Pantuck AJ, Belldegrun AS. PMID: 14670537.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    231. LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen. Cancer Res. 2003 Aug 15; 63(16):4952-9. Zisman A, Pantuck AJ, Bui MH, Said JW, Caliliw RR, Rao N, Shintaku P, Berger F, Gambhir SS, Belldegrun AS. PMID: 12941820.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    232. Current staging of renal cell carcinoma. Urol Clin North Am. 2003 Aug; 30(3):481-97, viii. Leibovich BC, Pantuck AJ, Bui MH, Ryu-Han K, Zisman A, Figlin R, Belldegrun A. PMID: 12953750.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    233. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer. 2003 Jun 15; 97(12):2995-3002. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz B, Belldegrun AS, Figlin RA. PMID: 12784334.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    234. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system. Prostate. 2003 Jun 01; 55(4):299-307. Freedland SJ, Pantuck AJ, Paik SH, Zisman A, Graeber TG, Eisenberg D, McBride WH, Nguyen D, Tso CL, Belldegrun AS. PMID: 12712409.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    235. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol. 2003 Jun; 169(6):2076-83. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS. PMID: 12771723.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    236. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology. 2003 Apr; 61(4):845-50. Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A. PMID: 12670587.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    237. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003 Apr 01; 55(1):71-80. Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS. PMID: 12640663.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    238. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol. 2003 Mar; 169(3):909-16. Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS. PMID: 12576811.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    239. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol. 2003 Mar; 169(3):899-903; discussion 903-4. Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, Belldegrun AS. PMID: 12576809.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    240. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 2003 Feb; 61(2):314-9. Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, Belldegrun AS. PMID: 12597937.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    241. Monoclonal antibody (MAB) in patients with advanced cancer. Curr Urol Rep. 2003 Feb; 4(1):11-2. Kim HL, Pantuck AJ, Zomorodian N, Belldegrun AS. PMID: 12537933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    242. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res. 2003 Feb; 9(2):802-11. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS. PMID: 12576453.
      View in: PubMed   Mentions: 196     Fields:    Translation:Humans
    243. Basic biology and clinical behavior of renal cell carcinoma. Cancer Treat Res. 2003; 116:69-89. Han KR, Pantuck AJ, Belldegrun AS. PMID: 14650826.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    244. Urologic oncology: extraordinary opportunities for discovery: highlights from the 2nd annual winter meeting of the society of urologic oncology december 1-2, 2001, bethesda, MD. Rev Urol. 2003; 5(1):26-8. Pantuck AJ, Zisman A, Belldegrun AS. PMID: 16985614; PMCID: PMC1472992.
      View in: PubMed   Mentions:
    245. Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. Transplantation. 2002 Dec 27; 74(12):1700-2. Perry KT, Zisman A, Gritsch HA, Pantuck A, Schulam PG. PMID: 12499884.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    246. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002 Dec 01; 20(23):4559-66. Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS. PMID: 12454113.
      View in: PubMed   Mentions: 199     Fields:    Translation:Humans
    247. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer. 2002 Sep 15; 95(6):1247-57. Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. PMID: 12216092.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    248. Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype. J Urol. 2002 Sep; 168(3):950-5. Zisman A, Chao DH, Pantuck AJ, Kim HJ, Wieder JA, Figlin RA, Said JW, Belldegrun AS. PMID: 12187197.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    249. PC-SPES: herbal formulation for prostate cancer. Urology. 2002 Sep; 60(3):369-75; discussion 376-7. Marks LS, DiPaola RS, Nelson P, Chen S, Heber D, Belldegrun AS, Lowe FC, Fan J, Leaders FE, Pantuck AJ, Tyler VE. PMID: 12350462.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    250. Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate? J Urol. 2002 Sep; 168(3):962-7. Zisman A, Pantuck AJ, Chao DH, Wieder JA, Dorey F, Said JW, Kernion JB, Figlin R, Belldegrun AS. PMID: 12187200.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    251. CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography. J Urol. 2002 Sep; 168(3):1193-8. Pantuck AJ, Berger F, Zisman A, Nguyen D, Tso CL, Matherly J, Gambhir SS, Belldegrun AS. PMID: 12187266.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    252. Positron emission tomography in urologic oncology. Cancer Control. 2002 Jul-Aug; 9(4):335-42. Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS. PMID: 12228759.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    253. Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Hum Gene Ther. 2002 May 01; 13(7):777-89. Pantuck AJ, Matherly J, Zisman A, Nguyen D, Berger F, Gambhir SS, Black ME, Belldegrun A, Wu L. PMID: 11975845.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    254. Changing concepts in the management of renal oncocytoma. Urology. 2002 May; 59(5):635-42. Chao DH, Zisman A, Pantuck AJ, Freedland SJ, Said JW, Belldegrun AS. PMID: 11992832.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    255. Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol. 2002 Mar 01; 20(5):1368-74. Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS. PMID: 11870181.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    256. A randomized phase III trial of high dose interleukin-2 versus subcutaneous interleukin-2/interferon. Curr Urol Rep. 2002 Feb; 3(1):11-2. Han KR, Pantuck AJ, Belldegrun AS. PMID: 12084213.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    257. Minimally invasive ablative approaches in the treatment of renal cell carcinoma. Curr Urol Rep. 2002 Feb; 3(1):13-20. Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS. PMID: 12084214.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    258. Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. Rev Urol. 2002; 4(3):103-11. Perry K, Zisman A, Pantuck AJ, Janzen N, Schulam P, Belldegrun AS. PMID: 16985666; PMCID: PMC1475990.
      View in: PubMed   Mentions: 3  
    259. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol. 2002 Jan; 167(1):71-4. Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. PMID: 11743278.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    260. Tumor markers for the early detection of bladder cancer. Front Biosci. 2002 Jan 01; 7:e19-26. Han KR, Pantuck AJ, Belldegrun AS, Rao JY. PMID: 11779696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    261. Cryosurgical ablation of renal tumors using 1.5-millimeter, ultrathin cryoprobes. Urology. 2002 Jan; 59(1):130-3. Pantuck AJ, Zisman A, Cohen J, Belldegrun A. PMID: 11796298.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    262. Gene and immune therapy for renal cell carcinoma. Int J Urol. 2001 Jul; 8(7):S1-4. Pantuck AJ, Zisman A, Belldegrun A. PMID: 11442668.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    263. Angiographic management of pseudoaneurysm and arteriocalyceal fistula following blunt trauma: case report and review of the literature. Can J Urol. 1998 Dec; 5(5):654-657. Goldstein DW, Pantuck AJ, Burno DK, Marmar JL, Lobby N. PMID: 11319042.
      View in: PubMed   Mentions: 3     Fields:    
    264. Genital hair strangulation in an uncircumcised boy. Can J Urol. 1997 Dec; 4(4):455. Pantuck AJ, Fleisher MH, Barone JG. PMID: 12735813.
      View in: PubMed   Mentions:    Fields:    
    Allan's Networks
    Concepts (642)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (54)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California